TransCon hGH

An investigational GHD treatment designed to improve patients' lives

An investigational GHD treatment designed to improve patients' lives

Vector-Smart-Object-copy

TransCon hGH is an investigational, long-acting human growth hormone prodrug administered weekly that releases somatropin as a potential therapy for children and adults with GHD.

Explore

You are about to access www.ascendispharma.us, which includes information intended for U.S. residents only. Click below to confirm.

Are you a U.S. resident?

If so, please confirm below to proceed to our U.S. website. If not, continue to our global website.